HeartSciences (HSCS) Net Income towards Common Stockholders (QoQ) (2021 - 2025)
HeartSciences (HSCS) Net Income towards Common Stockholders (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | HeartSciences | 6.51 Mn | 4.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 86.43% |
| Jul 31, 2025 | -725.02% |
| Apr 30, 2025 | 87.61% |
| Jan 31, 2025 | -5.71% |
| Oct 31, 2024 | -2.31% |
| Jul 31, 2024 | -725.19% |
| Apr 30, 2024 | 86.71% |
| Jan 31, 2024 | -2.51% |
| Oct 31, 2023 | -4.52% |
| Jul 31, 2023 | -717.56% |
| Apr 30, 2023 | 86.87% |
| Jan 31, 2023 | 0.88% |
| Oct 31, 2022 | -5.82% |
| Jul 31, 2022 | -476.81% |
| Apr 30, 2022 | -65.80% |
| Jan 31, 2022 | -19.77% |
| Oct 31, 2021 | -37.59% |